Research Reports
Farfetch Sold 60% More Clothes on its Websites Than Last Year
Last qtr, Farfech (FTCH) sold 6% more high-end clothing on its company websites, and 50% more goods over all outlets.
Exact Sciences’ Tests Detect Colon Cancer, Breast Cancer
Exat Sciences (EXAS) has a one-two punch against cancer in its Cologuard and Oncotype DX tests. But the stock is in neutral.
Invitae is Down-and-Out, But Still Has a Bright Future
Invitae (NVTA) is a leader in Genetic testing. But stoks like this are totally out of favor right now. But the future is bright.
Zoom’s Purchase of Five9 is Good for HubSpot Investors
Zoom’s merging with Five9, which makes customer service software. That’s good for HubSpot (HUBS) because it sets a “multiple”.
MercadoLibre is Spending to Grow, While Profits Suffer
MercadoLibre (MELI) is growing very rapidly, but has missed earnings estimates the past two qtrs, with losses each time.
Will Datadog Break Out? I Don’t Think So, Here’s Why
Data monitoring & analytics company Datadog (DDOG) was a darling in 2020, but 201 is rough because the high valuation.
Latest Profits
SE 2021 Q3
Sea (SE) expected to report qtrly profits (EPS):
Estimates: -$0.53 vs. -$0.68 = N/A
NET 2021 Q3
Cloudflare (NET) expected to report qtrly profits (EPS):
Estimates: -$0.04 vs. -$0.03 = +N/A
ROKU 2021 Q3
Roku (ROKU) expected to report qtrly profits (EPS):
Estimates: $0.12 vs. $0.35= +134%
DKNG 2021 Q3
DraftKings (DKNG) expected to report qtrly profits (EPS):
Estimates: -$0.52 vs. -$0.42 = N/A
BILI 2021 Q3
Bilibili (BILI) expected to report qtrly profits (EPS):
Estimates: -$0.42 vs. -$0.20 = N/A